Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

por Giné, Eva, de la Cruz, Fátima, Jiménez Ubieto, Ana, López Jimenez, Javier, Martín García-Sancho, Alejandro, Terol, M. José, González Barca, Eva, Casanova, María, de la Fuente, Adolfo, Marín-Niebla, Ana, Muntañola, Ana, González-López, Tomás José, Aymerich, Marta, Setoain, Xavier, Cortés-Romera, Montserrat, Rotger, Amanda, Rodríguez, Sonia, Medina Herrera, Alejandro, García Sanz, Ramón, Nadeu, Ferran, Beà, Silvia, Campo, Elías, López-Guillermo, Armando
Publicado 2022

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

por Gutierrez, Antonio, Bento, Leyre, Diaz‐Lopez, Antonio, Barranco, Gilberto, Garcia‐Recio, Marta, Lopez‐Guillermo, Armando, Dlouhy, Ivan, Rovira, Jordina, Rodriguez, Mario, Sanchez Pina, Jose María, Baile, Monica, Martín, Alejandro, Novelli, Silvana, Sancho, Juan‐Manuel, García, Olga, Salar, Antonio, Bastos‐Oreiro, Mariana, Rodriguez‐Salazar, Mª José, Fernandez, Ruben, de la Cruz, Fatima, Queizan, Jose Antonio, González de Villambrosia, Sonia, Cordoba, Raul, López, Andres, Luzardo, Hugo, García, Daniel, Sastre‐Serra, Jordi, Garcia, Juan Fernando, Montalban, Carlos, Cabanillas, Fernando, Rodríguez, Jose
Publicado 2020

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

por Maerevoet, Marie, Zijlstra, Josee M., Follows, George, Casasnovas, Rene-Olivier, Vermaat, J. S. P., Kalakonda, Nagesh, Goy, Andre, Choquet, Sylvain, Van Den Neste, Eric, Hill, Brian, Thieblemont, Catherine, Cavallo, Federica, De la Cruz, Fatima, Kuruvilla, John, Hamad, Nada, Jaeger, Ulrich, Caimi, Paolo, Gurion, Ronit, Warzocha, Krzysztof, Bakhshi, Sameer, Sancho, Juan-Manuel, Schuster, Michael, Egyed, Miklos, Offner, Fritz, Vassilakopoulos, Theodoros P., Samal, Priyanka, Ku, Matthew, Ma, Xiwen, Corona, Kelly, Chamoun, Kamal, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G., Canales, Miguel
Publicado 2021

Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma

por Chen‐Liang, Tzu‐Hua, Martín‐Santos, Taida, Jerez, Andrés, Rodríguez‐García, Guillermo, Senent, Leonor, Martínez‐Millán, Cristina, Muiña, Begoña, Orero, Mayte, Teruel, Anabel, Martín, Alejandro, Gómez‐Espuch, Joaquín, Kennedy, Kyra, Benet, Carmen, Raya, José María, Fernández‐González, Marta, de la Cruz, Fátima, Guinot, Marta, Villegas, Carolina, Ballester, Isabel, Baile, Mónica, Moya, María, López‐Jiménez, Javier, Frutos, Laura, Navarro, José Luis, Uña, Jon, Fernández‐López, Rosa, Igua, Carolina, Contreras, José, Sánchez‐Vañó, Raquel, Cozar, María del Puig, Tamayo, Pilar, Mucientes, Jorge, Sánchez‐Blanco, José Javier, Pérez‐Ceballos, Elena, Ortuño, Francisco José
Publicado 2017